Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients

Prostate

Volumn 71, Issue 16, 2011, Pages 1790-1795

  Aumayr, Klaus ^a   Breitegger, Michael ^a   Mazal, Peter R ^a   Koller, Anke ^a   Marberger, Michael ^a   Susani, Martin ^a   Haitel, Andrea ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

biochemical recurrence; nerves; prognostic value; prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER SURVIVAL; EXTRAPROSTATIC PERINEURAL SPREAD; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; TUMOR GROWTH;

BIOPSY; DISEASE-FREE SURVIVAL; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PERINEUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 80054072489     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21396     Document Type: Article

References (29)

1. Bastacky S, Walsh P, Epstein J,. Relationship between perineural tumor invasion on needle-biopsy and radical prostatectomy capsular penetration in clinical stage-b adenocarcinoma of the prostate. Am J Surg Pathol 1993; 17 (4): 336-341. (Pubitemid 23096823)
2. de la Taille A, Katz A, Bagiella E, Olsson C, O'Toole K, Rubin M,. Perineural invasion on prostate needle biopsy: An independent predictor of final pathologic stage. Urology 1999; 54 (6): 1039-1043.
3. de la Taille A, Rubin MA, Bagiella E, Olsson CA, Buttyan R, Burchardt T, Knight C, O'Toole KM, Katz AE,. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy? J Urol 1999; 162: 103-106. (Pubitemid 29420890)
4. Egan AJ, Bostwick DG,. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: Perineural invasion lacks significance on multivariate analysis. Am J Surg Pathol 1997; 21: 1496-1500. (Pubitemid 27528261)
5. Ravery V, Boccon-Gibod LA, Meulemans A, Dauge-Geffroy MC, Toublanc M, Boccon-Gibod L,. Predictive value of pathological features for progression after radical prostatectomy. Eur Urol 1994; 26: 197-201. (Pubitemid 24309664)
6. van den Ouden D, Kranse R, Hop WC, van der Kwast TH, Schröder FH,. Microvascular invasion in prostate cancer: Prognostic significance in patients treated by radical prostatectomy for clinically localized carcinoma. Urol Int 1998; 60: 17-24. (Pubitemid 28072434)
7. Byar DP, Mostofi FK,. Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 1972; 30: 5-13.
8. Maru N, Ohori M, Kattan MW, Scardino PT, Wheeler TM,. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum Pathol 2001; 32: 828-833. (Pubitemid 32803984)
9. Ohori M, Kattan M, Scardino PT, Wheeler TM,. Radical prostatectomy for carcinoma of the prostate. Mod Pathol 2004; 17: 349-359. (Pubitemid 41646612)
10. Ozcan F,. Correlation of perineural invasion on radical prostatectomy specimens with other pathologic prognostic factors and PSA failure. Eur Urol 2001; 40: 308-312. (Pubitemid 34701901)
11. McNeal JE, Yemoto CE,. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 1996; 20: 802-814. (Pubitemid 26230743)
12. Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA,. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989; 142: 763-768. (Pubitemid 19226718)
13. Sobin LH, Gospodarowicz M, Wittekind C,. TNM classification of malignant tumours. Oxford: UICC, Wiley-Blackwell; 2009. p. 256.
14. Epstein JI, Carmichael MJ, Pizov G, Walsh PC,. Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term followup. J Urol 1993; 150: 135-141. (Pubitemid 23175988)
15. Wheeler TM, Dillioglugil O, Kattan MW, Arakawa A, Soh S, Suyama K, Ohori M, Scardino PT,. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol 1998; 29: 856-862. (Pubitemid 28375994)
16. Humphrey PA, Andriole GL,. Prostate cancer diagnosis. Mol Med 2010; 107: 107-112.
17. Bostwick DG, Grignon DJ, Hammond ME, Amin MB, Cohen M, Crawford D, Gospadarowicz M, Kaplan RS, Miller DS, Montironi R, Pajak TF, Pollack A, Srigley JR, Yarbro JW,. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 995-1000. (Pubitemid 30602040)
18. Magi-Galluzzi C, Evans AJ, Delahunt B, Epstein JI, Griffiths DF, van der Kwast TH, Montironi R, Wheeler TM, Srigley JR, Egevad LL, Humphrey PA,. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: Extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 2011; 24: 26-38.
19. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Delmas V, Meulemans A, Toublanc M, Boccon-Gibod L,. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 1994; 44: 371-376. (Pubitemid 24273820)
20. Freedland SJ, Csathy GS, Dorey F, Aronson WJ,. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 2002; 167: 516-520. (Pubitemid 34074518)
21. Ukimura O, Troncoso P, Ramirez EI, Babaian RJ,. Prostate cancer staging: Correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension. J Urol 1998; 159: 1251-1259. (Pubitemid 28172808)
22. Vargas SO, Jiroutek M, Welch WR, Nucci MR, D'Amico AV, Renshaw AA,. Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection. Am J Clin Pathol 1999; 111: 223-228. (Pubitemid 29054950)
23. Rubin MA, Bassily N, Sanda M, Montie J, Strawderman MS, Wojno K,. Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma. Am J Surg Pathol 2000; 24: 183-189. (Pubitemid 30078706)
24. Sebo TJ, Cheville JC, Riehle DL, Lohse CM, Pankratz VS, Myers RP, Blute ML, Zincke H,. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: A report of 454 cases. Cancer 2001; 91: 2196-2204. (Pubitemid 32476386)
25. Bismar TA, Lewis JS, Vollmer RT, Humphrey PA,. Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol 2003; 27: 432-440. (Pubitemid 36368540)
26. O'Malley KJ, Pound CR, Walsh PC, Epstein JI, Partin AW,. Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy. Urology 2002; 59: 85-90. (Pubitemid 34059312)
27. Bostwick DG,. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 1994; 18: 796-803. (Pubitemid 24229402)
28. Epstein JI, Amin M, Boccon-Gibod L, Egevad L, Humphrey PA, Mikuz G, Newling D, Nilsson S, Sakr W, Srigley JR, Wheeler TM, Montironi R,. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol 2005; Suppl: 34-63.
29. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, Zattoni F,. Urology EAo [EAU guidelines on prostate cancer]. Actas Urol Esp 2009; 33: 13-126.